Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
—1,083.041,082.631,099.011,080.59——
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
—602.38602.38609.75599.75——
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
—1,242.831,229.311,258.881,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
—1,713.821,715.471,763.111,715.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
—639.99636.98644.04631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
—837.46840.30852.55840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
—214.22214.22218.25214.05——
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
—3,204.383,215.043,217.443,159.90——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
—925.38927.91949.76927.91——
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
—1,442.711,443.011,477.901,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
—2,361.342,391.002,399.182,354.52——
EKSO:NASDAQ
Ekso Bionics Holdings Inc
$12.01
+4.98%
(+0.57) 1D
$12.01
0.00% (0.00)
After hours
Closed: Apr 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EKSO...
Open
$11.45
High
$12.28
Low
$11.45
Mkt. cap
42.80M
Avg. vol.
73.11K
Volume
45.04K
52-wk high
$13.50
52-wk low
$2.75
EPS
-$4.91
Beta
0.78
Shares outstanding
3.56M
No. of employees
50
News stories
From sources across the web
Profile
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
About Ekso Bionics Holdings Inc
CEOScott Davis
Employees50
Founded2005
HeadquartersSan Rafael, California, United States
SectorMedical device
Websiteeksobionics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.38M
2.06M
4.23M
3.14M
Cost of goods sold
1.57M
1.24M
1.68M
1.47M
Cost of revenue
1.57M
1.24M
1.68M
1.47M
Research and development expenses
988.00K
852.00K
550.00K
31.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.08M
3.94M
3.40M
5.40M
Operating expense
5.07M
4.79M
3.95M
5.43M
Total operating expenses
6.64M
6.03M
5.63M
6.90M
Operating income
-3.26M
-3.98M
-1.40M
-3.76M
Other non operating income
-5.00K
-8.00K
-5.00K
20.00K
EBT including unusual items
-2.89M
-2.71M
-1.42M
-4.67M
EBT excluding unusual items
-2.71M
-2.71M
-1.42M
-3.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.89M
-2.71M
-1.42M
-4.67M
Net profit margin
-85.66%
-131.70%
-33.62%
-148.85%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-72.00K
-65.00K
-18.00K
-155.00K
Net interest expenses
-72.00K
-65.00K
-18.00K
-155.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.88M
-3.60M
-1.04M
-3.31M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer